Related Experiment Video
Updated: Jan 30, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Analyses on K-ras mutations and fascin expression in patients with cardia cancer
Li Wei1, Haiyan Chang2, Song Huo3
1Department of Pathology, Jining First People's Hospital, Jining, Shandong 272111, P.R. China.
Abstract:
Mutations of K-rat sarcoma (K-ras) in patients with cardia cancer and their effects on the expression of fascin were investigated. A total of 90 cardia cancer patients treated in Jining First People's Hospital from March 2014 to March 2017 were randomly selected. Genomic deoxyribonucleic acid (DNA) was extracted from paraffin-embedded cardia cancer specimens. Pyrosequencing was applied to detect sequences of K-ras gene in all patients and to analyze the mutations of K-ras gene. Then, genotyping of mutations at each mutation site was carried out using quantitative polymerase chain reaction (qPCR). The expression level of fascin in patients was measured via immunohistochemistry and qPCR. The results revealed that among 90 patients with cardia cancer, 21 patients had K-ras mutations (23.3%), including 20 cases of exon 12 mutation and 1 case of exon 13 mutation. Risk factor analyses revealed that alcohol abuse was a high risk factor for mutations (p<0.05). There was no significant difference in the mutation probability between heterozygotes and homozygotes for four mutations at codon 12 (p>0.05). The heterozygote at codon 13 had a higher mutation probability than homozygote (p<0.05). Immunohistochemistry suggested that the number of positive cells in the mutant group was larger than that in the non-mutant group (p<0.05). The results of qPCR showed that the expression level of fascin gene in the mutant group was 2.3 times higher than that in the non-mutant group (p<0.05). In conclusion, the probability of codon 12 mutation in K-ras gene is increased in patients with cardia cancer, and fascin is highly expressed in mutant patients, which is positively correlated with the mutations in K-ras gene.
Insights
Cardia cancer patients with K-ras gene mutations, particularly at codon 12, show significantly higher fascin protein expression. Alcohol abuse is identified as a risk factor for these K-ras mutations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cardia cancer is a significant health concern globally.
- K-ras gene mutations are implicated in various cancers.
- Fascin is a protein involved in cell motility and cancer progression.
Purpose of the Study:
- To investigate K-ras gene mutations in cardia cancer patients.
- To analyze the effect of K-ras mutations on fascin expression.
- To identify potential risk factors for K-ras mutations in cardia cancer.
Main Methods:
- Genomic DNA extraction from cardia cancer tissues.
- Pyrosequencing and quantitative polymerase chain reaction (qPCR) for K-ras mutation detection.
- Immunohistochemistry and qPCR for fascin expression analysis.
Main Results:
- K-ras mutations were found in 23.3% of cardia cancer patients, predominantly in exon 12.
- Alcohol abuse was identified as a significant risk factor for K-ras mutations.
- Fascin expression was significantly higher (2.3-fold) in patients with K-ras mutations compared to those without.
Conclusions:
- Codon 12 mutations in the K-ras gene are common in cardia cancer.
- Fascin is highly expressed in cardia cancer patients with K-ras mutations.
- Fascin expression is positively correlated with K-ras gene mutations in cardia cancer.
Related Concept Videos
The Ras Gene
Ras is a...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancers Originate from Somatic Mutations in a Single Cell
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Viral Mutations

